In the prostate-specific PTEN knock-out mouse model, the deletion of CD36 led to a reduction in fatty acid uptake and the abundance of oncogenic signaling lipids, thereby slowing down PCa progression [47]. The gene discussed is CD36; the disease is posterior cortical atrophy.